DK1585810T3 - Fremgangsmåde til dyrkning af celler til produktion af substanser - Google Patents

Fremgangsmåde til dyrkning af celler til produktion af substanser

Info

Publication number
DK1585810T3
DK1585810T3 DK03767406.6T DK03767406T DK1585810T3 DK 1585810 T3 DK1585810 T3 DK 1585810T3 DK 03767406 T DK03767406 T DK 03767406T DK 1585810 T3 DK1585810 T3 DK 1585810T3
Authority
DK
Denmark
Prior art keywords
glucose
limitation
dgl
culturing cells
produce substances
Prior art date
Application number
DK03767406.6T
Other languages
Danish (da)
English (en)
Inventor
Jochen Gaetgens
Christian Wandrey
Ruth Essers
Thomas Link
Thomas Noll
Kerstin Skopnik
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1585810T3 publication Critical patent/DK1585810T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK03767406.6T 2002-11-27 2003-11-07 Fremgangsmåde til dyrkning af celler til produktion af substanser DK1585810T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255508A DE10255508A1 (de) 2002-11-27 2002-11-27 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
PCT/DE2003/003693 WO2004048556A1 (de) 2002-11-27 2003-11-07 Verfahren zur kultivierung von zellen zur produktion von substanzen

Publications (1)

Publication Number Publication Date
DK1585810T3 true DK1585810T3 (da) 2010-06-07

Family

ID=32318751

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03767406.6T DK1585810T3 (da) 2002-11-27 2003-11-07 Fremgangsmåde til dyrkning af celler til produktion af substanser
DK10152393.4T DK2226381T3 (en) 2002-11-27 2003-11-07 Process for the cultivation of cells for production of compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10152393.4T DK2226381T3 (en) 2002-11-27 2003-11-07 Process for the cultivation of cells for production of compounds

Country Status (12)

Country Link
US (2) US20060127975A1 (enExample)
EP (3) EP1585810B1 (enExample)
JP (2) JP4469283B2 (enExample)
AT (1) ATE462013T1 (enExample)
CY (2) CY1110267T1 (enExample)
DE (2) DE10255508A1 (enExample)
DK (2) DK1585810T3 (enExample)
ES (3) ES2749217T3 (enExample)
HU (1) HUE028862T2 (enExample)
PT (1) PT1585810E (enExample)
SI (3) SI2226381T1 (enExample)
WO (1) WO2004048556A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312184T3 (es) 1997-03-21 2009-02-16 Chugai Seiyaku Kabushiki Kaisha Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas.
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
EP1623019B2 (en) 2003-05-15 2017-01-25 Wyeth LLC Restricted glucose feed for animal cell culture
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
AU2015203309B2 (en) * 2009-10-26 2016-05-05 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
AU2016210748B2 (en) * 2009-10-26 2018-03-01 Chugai Seiyaku Kabushiki Kaisha Method for the production of a glycosylated immunoglobulin
KR102071834B1 (ko) * 2009-10-26 2020-01-30 에프. 호프만-라 로슈 아게 글리코실화된 면역글로불린의 제조 방법
TWI563090B (en) * 2009-12-22 2016-12-21 Dsm Ip Assets Bv The preparation of caprolactam from 6-amino caproic acid obtained in a fermentation process
EP2638067A2 (en) 2010-11-08 2013-09-18 Genentech, Inc. Subcutaneously administered anti-il-6 receptor antibody
RU2674996C2 (ru) 2013-07-04 2018-12-14 Ф. Хоффманн-Ля Рош Аг Иммуноферментный анализ с подавлением интерференции для определения антител к лекарствам в образцах сыворотки
ES3005909T3 (en) 2014-03-19 2025-03-17 Pfizer Method of cell culture
WO2017051347A2 (en) 2015-09-23 2017-03-30 Pfizer Inc. Cells and method of cell culture
EP3891292A1 (en) 2018-12-06 2021-10-13 Pfizer Inc. Cells with reduced inhibitor production and methods of use thereof
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657863A (en) * 1982-07-02 1987-04-14 Celanese Corporation Stabilization of a mutant microorganism population
JPH066054B2 (ja) * 1987-10-15 1994-01-26 帝人株式会社 動物細胞の培養方法
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
US5443968A (en) 1992-05-01 1995-08-22 Teijin Limited Fed batch culture method for protein secreting cells
GB9506249D0 (en) * 1995-03-27 1995-05-17 Karobio Ab Media for insect cell cultures
US6156570A (en) * 1997-03-20 2000-12-05 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6338964B1 (en) * 1999-05-07 2002-01-15 Bayer Corporation Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration

Also Published As

Publication number Publication date
PT1585810E (pt) 2010-05-05
JP4469283B2 (ja) 2010-05-26
DK2226381T3 (en) 2016-04-11
EP2275530A3 (de) 2012-05-23
CY1117558T1 (el) 2017-04-26
SI2275530T1 (sl) 2019-11-29
WO2004048556A1 (de) 2004-06-10
ES2340377T3 (es) 2010-06-02
EP2275530B1 (de) 2019-08-07
US20140329277A1 (en) 2014-11-06
EP2226381B1 (de) 2016-03-09
EP2226381A1 (de) 2010-09-08
DE50312554D1 (de) 2010-05-06
HUE028862T2 (en) 2017-01-30
EP1585810B1 (de) 2010-03-24
SI2226381T1 (sl) 2016-05-31
SI1585810T1 (sl) 2010-06-30
ES2567161T3 (es) 2016-04-20
ES2749217T3 (es) 2020-03-19
US20060127975A1 (en) 2006-06-15
JP2006507821A (ja) 2006-03-09
JP2010110331A (ja) 2010-05-20
ATE462013T1 (de) 2010-04-15
CY1110267T1 (el) 2015-01-14
JP5221573B2 (ja) 2013-06-26
EP2275530A2 (de) 2011-01-19
DE10255508A1 (de) 2004-06-17
EP1585810A1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
CY1117558T1 (el) Μεθοδος για καλλιεργεια κυτταρων για παραγωγη ουσιων
IL250313B (en) Expansion of renewable stem cell populations
DE602004014158D1 (de) Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität
DK1623019T3 (da) Begrænset glucosetilførsel til dyrecellekultur
DK1428878T3 (da) Fremgangsmåde til produktion og oprensning af erythropoietin
IL132598A0 (en) Method for purifying lactic acid
WO2005028626A3 (en) Cell culture media
WO2004050826A3 (en) Method of dynamically culturing embryonic stem cells
ATE449175T1 (de) Bakterielle produktion von interferon-beta polypeptiden
TR200401091T4 (tr) Gelişim faktörleri ve L-glutamin içeren hücre kültürü besiyeri
UA92157C2 (ru) Способ продуцирования гормона роста
DK1495112T3 (da) Cellekulturmedium
BR0314402A (pt) Expansão ex-vivo de populações de células raìzes em culturas celulares mononucleares
ATE340851T1 (de) Methode zur erhöhung der fermentationsgeschwindigkeit von hefe
DK1554374T3 (da) Fremgangsmåde til storskala T-lymfocytdyrkning i et homogent system
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
MY146013A (en) Process for purifying mesotrione
TW200510011A (en) A method for regeneration of bone
BRPI0403200A (pt) Método para recrescimento de células embriogênicas crioconservadas de conìferas
AU2002214085A1 (en) Method for producing proteins by electroporation
DE50013563D1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
WO2005046581A3 (en) P18 in stem cell manipulations
AU2003242533A1 (en) Glutamine-free medium
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
DE60132466D1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen